Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study
Journal of Clinical Medicine · 05.06.2026 · 15 (11) · 4389
DOI: 10.3390/jcm15114389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.06.2026. Verfasst von Marilina García-Aranda und 12 weiteren Autor:innen. Beteiligte Einrichtung: B-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Pl…. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Basque Health Department, European Union.
Abstract (Originalsprache)
Background
As survival after colorectal cancer (CRC) has improved, an increasing proportion of patients live beyond five years, making long-term outcomes increasingly relevant. In addition to cancer-related mortality, survivors remain at risk of death from other causes influenced by clinical and psychosocial vulnerabilities.
Methods
We conducted a 10-year prospective cohort study including 838 patients with stage I–IV CRC treated in public hospitals in the Basque Country (Spain). Patients were recruited between November 2010 and December 2012 and followed for up to 10 years after surgery. Clinical, sociodemographic, lifestyle, and patient-reported outcomes were collected. Competing risk regression models (Fine-Gray) were used to estimate sub-distribution hazard ratios (sHRs) for CRC-specific and non-CRC mortality, stratified by tumor site and sex.
Results
After 10 years, 40% of patients had died, with 66% of deaths attributable to CRC and 34% to other causes. CRC-specific mortality was mainly driven by tumor-related factors, including advanced stage (stage IV: sHR 7.18, p < 0.001) and residual disease after surgery (R1/R2: sHR 2.68; p < 0.001), with larger effect sizes observed in rectal cancer. In contrast, non-CRC mortality was associated with patient vulnerability, including age ≥75 years (sHR 3.57, p < 0.001), absence of adjuvant chemotherapy (sHR 5.59, p < 0.001), anemia, alcohol consumption, and poor functional status. Patients with rectal cancer and women reported poorer baseline quality of life. Sex-stratified analyses suggested differential patterns of vulnerability, with psychosocial and quality-of-life-related factors appearing more relevant in women, whereas lifestyle and clinical factors appeared more prominent in men.
Conclusions
Long-term mortality in CRC reflects the interplay between tumor-related factors and patient vulnerability. Competing risk models allow a more accurate characterization of cause-specific outcomes and may help identify high-risk subgroups for tailored follow-up and management strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- B-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
- Research and Innovation Unit, Hospital Universitario Costa del Sol, 29602 Marbella, Spain.
- Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Surgical Specialties, Biochemistry and Immunology Department, Faculty of Medicine, University of Málaga, 29010 Málaga, Spain.
- Research Unit, Osakidetza Basque Health Service, Barrualde-Galdakao Integrated Health Organisation, Galdakao-Usansolo Hospital, 48960 Galdakao, Spain.
- Biosistemak Institute for Health System Research, Gran Vía, 1, 48001 Bilbao, Spain.
ORCID-Profile: Marilina García-Aranda, Eloísa Urrechaga, Josefa Ferreiro, Isabel Portillo, Marta Jiménez-Toscano, Maria Jose Legarreta, Urko Aguirre
Förderung
- Instituto de Salud Carlos III
- Basque Health Department
- European Union
Zitieren
APA
García-Aranda, M., Martín-García, D., Gallejones-Eskubi, J., Urrechaga, E., Ferreiro, J., Portugal, V., Portillo, I., Jiménez-Toscano, M., Legarreta, M. J., Quintana, J. M., Redondo, M., Aguirre, U., & REDISSEC/CARESS-CCR Group (2026). Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. Journal of Clinical Medicine, 15(11), 4389. https://doi.org/10.3390/jcm15114389
Vancouver
García-Aranda M, Martín-García D, Gallejones-Eskubi J, Urrechaga E, Ferreiro J, Portugal V, et al. Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. Journal of Clinical Medicine. 2026;15(11):4389. doi:10.3390/jcm15114389
BibTeX
@article{GarcaAranda2026,
author = {García-Aranda, Marilina and Martín-García, Desireé and Gallejones-Eskubi, Janire and Urrechaga, Eloísa and Ferreiro, Josefa and Portugal, Vicente and Portillo, Isabel and Jiménez-Toscano, Marta and Legarreta, Maria Jose and Quintana, José María and Redondo, Maximino and Aguirre, Urko and REDISSEC/CARESS-CCR Group, REDISSEC/CARESS-CCR Group},
title = {Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4389},
doi = {10.3390/jcm15114389}
}
EUVIMED